Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

NCT04115410 is registered in ClinicalTrials.gov with Sungkyunkwan University as lead sponsor.

NCT NCT04115410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04115410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
Lead sponsor
Sungkyunkwan University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2020
Completion date
December 31, 2021
Enrollment
4,724 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung, immune-related adverse events